Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the jetpack-backup domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/vgbdoo6u2d7y/public_html/mcmillanresearch.com/wp-includes/functions.php on line 6121
Pfizer Slap on the Wrist well Worth the Financial Gains! - McMillan Research Limited
Select Page
Responsive Centered YouTube Video
Pfizer faces criticism for COVID-related social media posts, casting doubt on vaccine safety
  • Pfizer criticized for COVID social media posts damaging pharmaceutical industry reputation 0:03

  • Comparison made to past incidents like Credit Suisse in Switzerland 0:21

  • Discussion on potential long-term effects of vaccines and past vaccine-related issues 1:53

  • Challenges faced by those questioning vaccine safety and risks 2:02

  • Medium and long-term effects of vaccines highlighted with past example of narcolepsy 2:27

  • Article links Pfizer’s actions to discredit on pharmaceutical industry 3:00

Regulatory breaches and misleading claims by Pfizer regarding COVID-19 vaccine promotion
  • Pfizer breached regulatory code five times, including misleading claims and promoting unlicensed medicines 3:28

  • Complaint raised about misleading COVID-19 vaccine promotion on social media by Pfizer employees 4:11

  • Public misunderstanding of relative risk reduction vs. absolute risk reduction in vaccine efficacy 5:13

  • Promotion of vaccine as 95% effective without clarifying relative risk reduction 6:04

  • Immediate reporting of misinformation by vigilant individual regarding Pfizer’s claims 6:37

  • Pharmaceutical industry’s silence on Pfizer’s misleading promotion despite industry awareness 7:00

Pfizer faces repercussions for breaching social media guidelines, risking industry reputation
  • Credit Suisse found guilty of money laundering charges in Switzerland Criminal Court 7:08

  • Damages credibility of Swiss banking sector, drawing industry into disrepute 7:30

  • PMCA provides social media guidance for pharmaceutical companies 8:19

  • Fisa reprimanded multiple times for misleading statements about vaccines 9:57

Investigation into Pfizer's misleading marketing tactics resulted in a minimal financial penalty compared to massive profits from COVID vaccines
  • Pfizer faced multiple cases related to misleading claims on social media platforms 10:34

  • European parliamentary question raised concerns about the taxation of Pfizer’s $30 billion profits from COVID vaccines 11:22

  • The delay in the ruling on Pfizer’s case raises questions about the legal tactics employed by the company 12:10

  • Comparisons with previous complaints against other companies show a longer timeframe for resolution in Pfizer’s case 13:02

Lack of accountability in pharmaceutical industry despite financial gains and public health concerns
  • Industry’s silence on vaccine benefits and risks in November 2020 14:28

  • Questioning the ethics of prioritizing profit over public interest 15:04

  • Damage to public trust in pharmaceutical industry due to COVID vaccine campaign 15:49

  • Concerns about the long road to rebuilding public trust 16:01